Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04599725 · ClinicalTrials.gov registry record
Feasibility of Telemedicine Medical Abortion
A clinical trial of Pregnancy, sponsored by Gynuity Health Projects.
- Completed
- Registry status
- 413
- Enrollment target
- 15
- Study locations
NCT04599725: Completed study of Pregnancy, sponsored by Gynuity Health Projects.
NCT04599725 is a study of Pregnancy that has completed, run by Gynuity Health Projects. The registered enrollment target is 413 participants, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (53% lower). The trial reports 15 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04599725, a study of Pregnancy, has completed, sponsored by Gynuity Health Projects.
- COMPLETED
- Registry status
- 413 participants
- Enrollment target
- 15
- Study locations
Study Summary
This pilot study is designed to obtain data on the safety, acceptability, and feasibility of providing abortion by direct-to-patient telemedicine and mail.
Conditions Studied
Interventions
- DRUG medical abortion
Study Locations (15)
Colorado
- Planned Parenthood of the Rocky Mountains - Denver
District of Columbia
- Carafem - Washington D.C.
Georgia
- Carafem - Atlanta
Hawaii
- The University of Hawaii Women's Options Centers - Honolulu
Illinois
- Carafem - Skokie
Iowa
- Emma Goldman Clinic - Iowa City
Maine
- Maine Family Planning - Augusta
Maryland
- Carafem - Chevy Chase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 413 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2021-10-01 |
What the finished NCT04599725 record still lists
NCT04599725 is an observational study that tracks outcomes without assigning an intervention. The registered 413 participants enrollment target is mid-sized for trials with a published cap, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (53% lower).
The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which medical abortion is the first listed.
NCT04599725 lists 15 locations in 15 states (Colorado, District of Columbia, Georgia).
Frequently Asked Questions
What is clinical trial NCT04599725 about?
NCT04599725 is a clinical study titled "Feasibility of Telemedicine Medical Abortion". This pilot study is designed to obtain data on the safety, acceptability, and feasibility of providing abortion by direct-to-patient telemedicine and mail.
What is the current status of trial NCT04599725?
This trial is currently completed. The enrollment target is 413 participants. The study started on 2020-10-01. Estimated completion is 2021-10-01.
What conditions does trial NCT04599725 study?
This clinical trial studies the following conditions: Pregnancy.
What interventions are being tested in trial NCT04599725?
The interventions under investigation include: medical abortion (DRUG).
Who is sponsoring clinical trial NCT04599725?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04599725 being conducted?
This trial has 15 study locations across Colorado, District of Columbia, Georgia, Hawaii, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04599725's enrollment target sits among peer trials
413 57th of 191 higher than 135 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03592472 · 413 participants · Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- NCT06697197 · 413 participants · Phase 1
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
- NCT04776941 · 414 participants · NA
Expressive Writing for the Management of Stress in Cancer Survivors
- NCT06792552 · 414 participants · Phase 1
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI